Ascendiant Capital analyst Ed Woo initiates coverage on GRI Bio, Inc. (NASDAQ: GRI) with a Buy rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE